Summary
Purpose: To determine whether or not subtypes of intellectual functioning are suitable to predict further cognitive decline in individuals with mild cognitive impairment. Design: naturalistic longitudinal study (mean interval 2.7 years). Patients: 41 subjects with mild cognitive impairment who attended a memory clinic. Methods: SID AM, CT, SPECT, and ApoE genotype. Results: At follow-up, 8 out of 41 patients (19.5%) with MCI had progressed to dementia, 8 patients (19.5%) had improved to normal levels of cognitive functioning, 25 patients (61%) had remained stable within the MCI group. At baseline the two prognostic groups differed significantly with regard to age, memory functions, orientation, and the degree of atrophy of the left medial temporal lobe on CT scan. Conclusion: The majority of MCI patients in this study remained cognitively stable within the observation period. Patients with older age, poorer test performance on memory tasks and orientation deficits are at higher risk of progressive decline to dementia. CT measures of medial temporal lobe atrophy may be a sensitive parameter of group discrimination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almkvist O (1994) Neuropsychological deficits in vascular dementia in relation to Alzheimer’s disease: reviewing evidence for functional similarity or divergence. Dementia 5(3–4): 203–209
Almkvist O, Backman L, Basun H, Wahlund LO (1993) Patterns of neuropsychological performance in Alzheimer’s disease and vascular dementia. Cortex 29(4): 661–673
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed rev. American Psychiatric Association, Washington DC
Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J (1988) Age-specific norms for the Mini-Mental State Exam. Neurology 38(10): 1565–1568
Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R (1996) High apolipoprotein E epsilon 4 allele frequency in age-related memory decline. Ann Neurol 39(4): 548–551
Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 15;349(9054): 763–765
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82(4): 239–259
Christensen H, Birrell P (1991) Explicit and implicit memory in dementia and normal ageing. Psychol Res 53(2): 149–161
Clarfield AM (1988) The reversible dementias: do they reverse? Ann Intern Med 15;109(6): 476–486
Cooper B, Bickel H, Schäufele M (1996) Early development and progression of dementing illnesss in the elderly: a general praxis based study. Psychol Med 26: 411–419
Crook T, Larrabee GJ (1988) Age-associated memory impairment: diagnostic criteria and treatment strategies. Psychopharmacol Bull 24(4): 509–514
Dawe B, Procter A, Philpot M (1992) Concepts of mild memory impairment in the elderly and their relationship to dementia: a review. Int J Geriatr Psychiatry 443–449
de Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, De Santi S, Smith G, Ferris SH, Noz M, et al (1993) The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 14(4): 897–906
de Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, de Santi S, McRae T, Ferris SH, Reisberg B, Ince C, Rusinek H, Bobinski M, Quinn B, Miller DC,Wisniewski HM (1997) Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging 18: 1–11
Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y (1997) Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45(3): 321–328
Erkinjuntti T, Lee DH, Gao F, Steenhuis R, Eliasziw M, Fry R, Merskey H, Hachinski VC (1993) Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer’s disease. Arch Neurol 50(3): 305–310
Flicker C, Ferris SH, Reisberg B (1991) Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41: 1006–1009
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12/3:189–198
Forsti H, Hentschel F, Sattel H, Geiger-Kabisch C, Besthorn C, Czech C, Monning U, Beyreuther K (1995) Age-associated memory impairment and early Alzheimer’s disease. Only time will tell the difference. Arzneimittelforschung 45(3A): 394–397
Frisoni GB, Beltramello A, Weiss C, Geroldi C, Bianchetti A, Trabucchi M (1996) Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol 17(5): 913–923
Gertz HJ, Xuereb JH, Huppert FA, Brayne C, Kruger H, McGee MA, Paykel ES, Harrington CR, Mukaetova-Ladinska EB, O’Connor DW, Wischik CM (1996) The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci 246(3): 132–136
Gertz HJ, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E, Harrington C, Mukaetova-Ladinska E, Arendt T, Wischik CM (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease. Acta Neuropathol 95: 154–156
Gurland BJ, Dean L, Copeland J, Gurland B, Golden R (1982) Criteria for diagnosis of dementia in the communitiy elderly. Gerontologist 22: 180–186
Gurland BJ, Copeland JRM, Kuriansky J, Kelleher M, Sharpe L, Dean LL (1983) The mind and mood of ageing: mental health problems in the communitiy elderely in New York and London. Haworth Press, New York
Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G (1997) The impact of apolipoprotein E4 on cause of death in Alzheimer’s disease. Neurology 49(1): 76–81
Hachinski VC, Iliff LD, Zilkha E, Boulay GA du, McAllister VL, Marshall J, Roth M, Russell RW Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637
Hallman DM, Boerwinckle E, Saha N, et al (1991) Apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338–349
Haxby JV, Grady CL, Friedland RP, Rapoport SI (1987) Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: longitudinal confirmation. J Neural Transm [Suppl] 24: 49–53
Helisalmi S, Linnaranta K, Lehtovirta M, Mannermaa A, Heinonen O, Ryynanen M, Riekkinen P Sr, Soininen H (1996) Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci Lett 16;205(1): 61–64
Henderson AS (1986) Epidemiology in mental illness. In: Häfner H, Moschell G, Sartorius N (eds) Mental health in the elderly. Springer, Berlin Heidelberg New York Tokyo, pp 29–34
Henderson AS, Huppert FA (1984) The problem of mild dementia. Psychol Med 14: 5–11
Horn R, Ostertun B, Fric M, Solymosi L, Steudel A, Moller HJ (1996) Atrophy of hippocampus in patients with Alzheimer’s disease and other diseases with memory impairment. Dementia 7(4): 182–186
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572
Knapp WH, Dannenberg C, Marschall B, Zedlick D, Löschmann K, Bettin S, Barthel H, Seese A (1996) Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function. Eur J Nucl Med 23: 878–888
Kral VA (1962) Senescent forgetfulness: benign and malignant. Can Med Assoc J 86:257–260
Kral VA (1978) Benign senile forgetfulness. In: Katzman R, Terry RD, Bick KL (eds) Alzheimer’s disease: senile dementia and related disorders, vol 7. Ageing. Raven, New York, pp 47–51
Kurz A, Egensperger R, Lautenschlager N, Haupt M, Altland K, Graeber MB, Muller U (1995) The apolipoprotein E gene and Alzheimer disease phenotype. Z Gerontol Geriatr 28(3): 195–199
Launer LJ, Scheltens P, Lindeboom J, Barkhof F, Weinstein HC, Jonker C (1995) Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates. Neurology 45(4): 747–752
Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, Kaplan EF, D’Agostino RB (1995) The “preclinical phase” of probable Alzheimer’s disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 52(5): 485–490
Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA (1994) Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44: 1427–1432
Mattis S (1988) Dementia rating scale. Anonymous Psychological Assessment Resources, Odessa, FL
Meyer JS, Shirai T, Akiyama H (1997) Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging 18: 1–11
Mitrushina M, Satz P (1991) Effect of repeated administration of a neuropsychological battery in the elderly. J Clin Psychol 47(6): 790–801
Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J (1994) Predictive value of apolipoprotein E genotyping in Alzheimer’s disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 36(6): 889–895
O’Connor DW, Pollitt PA, Hyde JB, Fellows JL, Miller ND, Roth M (1990) A follow-up study of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand 81(1): 78–82
O’Connor DW, Pollitt PA, Jones BJ, Hyde JB, Fellowes JL, Miller ND (1991) Continued clinical validation of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand 83(1): 41–45
Oppenheim G (1994) The earliest signs of Alzheimer’s disease. J Geriatr Psychiatry Neurol 7: 116–120
Petersen RC (1995a) Normal aging, mild cognitive impairment, and early Alzheimer’s disease. The Neurologist 1: 326–344
Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG (1994) Memory function in very early Alzheimer’s disease. Neurology 44: 867–872
Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995b) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 273: 1274–1278
Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN (1996) Predictive value of ApoE genotyping in incipient Alzheimer’s disease. Ann NY Acad Sci 802: 58–69
Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993a) Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 342: 697–699
Reed BR, Jagust WJ, Scab JP, Ober BA (1989) Memory and regional blood cerebral blood flow in mildly symptomatic Alzheimer’s disease. Neurology 39: 1537–1539
Reifler BV (1982) Arguments for abandoning the term pseudodementia. J Am Geriatr Soc 30(10):665–668
Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9): 1136–1139
Richards M, Stern Y, Mayeux R (1993) Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 43: 2184–2188
Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980) Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7: 5, 486–488
Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149: 698–709
Rubin EH, Storandt M, Miller JP, Grant EA, Kinscherf DA, Morris JC, Berg L (1993) Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type. Arch Neurol 50(4): 380–383
Small GW, La Rue A, Komo S, Kaplan A, Mandelkern MA (1995) Predictors of cognitive change in middle-aged and older adults with memory loss. Am J Psychiatry 152: 1757–1764
Small GW, Komo S, La Rue A, Saxena S, Phelps ME, Mazziotta JC, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD (1996) Early detection of Alzheimer’s disease by combining apolipoprotein e and neuroimaging. Ann NY Acad Sci 802:70–78
Smith AD, Jobst KA (1996) Use of structural imaging to study the progression of Alzheimer’s disease. Br Med Bull 52(3): 575–586
St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A (1994) Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 18; 176(1): 45–46
Strittmatter WJ, Saunders AM, Smechel D, et al (1993) Apolipoprotein E: high-avidity binding to the B-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer’s disease. Proc Natl Acad Sci USA 90: 1977–1981
Terry R, Katzmann R (1983) Senile dementia of the Alzheimer type: defining a disease. In: Katzmann R, Terry R (eds) The neurology of aging. F.A. Davis, Philadelphia
Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, Dunn E, St. George-Hyslop PH (1996a) Prediction of probable alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology 46: 661–665
Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H, McLachlan DR, St George-Hyslop PH (1996b) A prospective study of the clinical utility of ApoE genotype in theprediction of outcome in patients with memory impairment. Neurology 46(1): 149–154
Tierney MC, Szalai P, Snow GW, Fisher RH (1996c) The prediction of Alzheimer disease: the role of patient and informant perceptions of cognitive deficits. Arch Neurol 53: 423–427
Troster AI, Moe KE, Vitiello MV, Prinz PN (1994) Predicting long-term outcome in individuals at risk for Alzheimer’s disease with the dementia rating scale. J Neuropsychiatry Clin Neurosci 6: 54–57
Tsai MS, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, Ivnik RJ, Thibodeau SN (1994) Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 54(4): 643–649
Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer’s disease. use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer’s Disease. Arch Neurol 49: 448–452
Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158–1159
World Health Organisation (1990) International classification of diseases, 10th edition. WHO, Geneva
Youngjohn JR, Crook TH 3d (1993) Learning, forgetting, and retrieval of everyday material across the adult life span. J Clin Exp Neuropsychol 15(4): 447–460
Zaudig M (1992) A new systematic method of measurement and diagnosis of “mild cognitive impairment” and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr 4 [Suppl 2]: 203–219
Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, Morinigo A, Mombour W (1991) SID AM — A structured interview for the diagnosis of dementia of the Alzheimer’s type, multiinfarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 21: 225–236
Zola-Morgan S, Squire LR, Amaral DG (1986) Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 6(10): 2950–2967
Zola-Morgan S, Squire LR, Amaral DG (1986) Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 6(10): 2950–2967
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Wolf, H. et al. (1998). The prognosis of mild cognitive impairment in the elderly. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7508-8_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83112-0
Online ISBN: 978-3-7091-7508-8
eBook Packages: Springer Book Archive